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Introduction: This study investigated the effects of carbohydrate and protein (CHO+Pro) 
supplementation during intensified training on cardiovascular adaptations and cycling 
performance.  Methods: Five cyclists (VO2peak = 62.6 ± 10.7 ml/kg/min) performed two 
27-day training protocols while receiving either CHO or CHO+Pro supplements. The 
exercise protocols consisted of 7 days of normal training (NT), 10 days of intensified 
cycle training (ICT; 100% increase in average training duration versus NT), and 10 days 
of reduced volume training (RVT; reduction in training duration to 60% of NT). 
Performance was assessed by a 30-km time trial following 120 min of constant-load 
cycling and VO2peak testing. Other physiological measures were assessed at rest (heart 
rate, hematocrit, hemoglobin, and albumin) and during exercise (heart rate, ventilation, 
RER, RPE, VO2, glucose, and lactate). Supplements were consumed during exercise (750 
ml·hr-1; CHO = 6% concentration; CHO+PRO = 6% CHO, 2% Pro concentrations) and 
immediately following exercise (9.93 ml of fluid·kg BW- 1; CHO = 1.2 g CHO·kg BW-1; 
CHO+PRO = 1.2 g CHO·kg BW-1 + 0.3 g Pro·kg BW-1). Data was analyzed using 
magnitude-based inferences. Results: Time to complete the 30-km TT and average TT 
power were ‘likely’ impaired following ICT, with no differences between treatments. 
Following RVT, time to complete the 30-km TT and average TT power were ‘likely’ 
improved versus ICT, with no differences between treatments. Between!NT!and!ICT!
constant2load!HR!significantly!decreased!(independent!of!treatment),!with!a!‘very!
likely’!larger!reduction!with!CHO+Pro!(135±13 bpm to 128±10 bpm) versus CHO 
(133±15 bpm to 132±13 bpm). Between NT and RVT, constant-load HR also ‘very 
likely’ declined to a greater extent with CHO+Pro (135±13 bpm to 132±14) than with 
!
vii!
CHO (133±15 to 138±16 bpm). Serum albumin was ‘likely’ increased following ICT and 
RVT (independent of treatment), but differences between treatments were ‘unclear’. 
Conclusion: These findings suggest exercising heart rates in well trained-cyclists are 
attenuated with carbohydrate and protein supplementation, although the cause of the 
reduced in HR is unclear. In addition, the implications of these findings require further 
study, as overall exercise tolerance and adaptations following intensified training were 






! Periods of intensified training are often used by endurance athletes in an attempt 
to enhance performance (20). When intensified training is followed by adequate 
recovery, it is common for athletes to experience improvements in performance 
compared to baseline, known as a “supercompensation” effect (20, 26). During 
intensified training it is common to experience reductions in global mood scores, 
maximum heart rate, VO2max, muscle glycogen levels, and an increase in perceived 
exertion during exercise (19, 26). This can result in short-term decrements in 
performance, known as overreaching (18, 20). However, continued heavy training while 
experiencing overreaching may ultimately lead to overtraining (19–21, 26). Overtraining 
is classified as an accumulation of training stress that leads to long-term decrements in 
performance (18–21, 26).  
 Nutritional interventions have commonly been implemented to promote recovery 
during and following periods of intensified training. High carbohydrate (CHO) diets have 
been shown to improve glycogen re-synthesis (40, 41), and improve performance in 
subsequent exercise following heavy training (1, 18, 41). Timing of CHO consumption is 
also important during heavy training. Dietary CHO consumption immediately after 
training results in higher rates of muscle glycogen re-synthesis, versus when CHO 
consumption is delayed (18, 23, 40). 
 A particular concern during periods of intensified training is muscle glycogen 
stores. Muscle glycogen depletion can occur after repeated bouts of high-intensity 




lead to fatigue and decrements in performance (9, 20). Evidence suggests that increased 
dietary CHO intake during heavy training may attenuate overtraining symptoms (1, 18). 
Achten et al. (1) observed that a high carbohydrate diet (8.5 g/kg/day) resulted in better 
maintenance of physical performance and mood scores compared to lower carbohydrate 
intake (5.4 g/kg/day) following a period of intensified training. Similarly, Halson et al. 
(18) observed that 8-days of intensified cycle training with low-carbohydrate 
supplementation (2% solution before, during, and immediately following each exercise 
session) resulted in significantly greater declines in time to fatigue, and mood scores 
when compared to high-carbohydrate supplementation (6% solution before and during 
exercise and a 20% solution immediately following each exercise session). These 
findings suggest that higher CHO intakes, particularly when fed during/post-exercise may 
help to improve tolerance to periods of intensified training. 
 The effects of supplemental protein on recovery from heavy aerobic training have 
also been investigated in recent years. Numerous studies have reported that co-ingestion 
of carbohydrate and protein (CHO+Pro) during short-term recovery following heavy 
exercise improves performance in subsequent exercise versus CHO alone (2, 3, 5, 7, 25, 
27, 32, 38, 43). Enhanced glycogen re-synthesis (4, 24, 28, 46), and/or reduced muscle 
damage (15, 17, 29–31, 37, 42, 44) are possible explanations for improvements in 
performance, though not all studies have reported these benefits (6, 36, 37, 39).  
 The short-term recovery benefits of CHO+Pro beverages are potentially important 
for athletes. However, the effects of CHO+Pro ingestion on exercise tolerance, training 
adaptations and performance during sustained periods of heavy training/competition are 




6 days of training, and reported attenuated creatine kinase (CK) levels (15, 29, 42) and 
decreased muscle soreness (29). However, it is unclear whether regular intake of 
CHO+Pro beverages improves performance following heavy training to a greater degree 
than CHO beverages. Witard et al. (45) examined the effects of increased dietary protein 
consumption, during a 1 week period of intensified training and the subsequent effects on 
performance and mood. When compared to a normal protein intake of 1.5 g⋅kg BW-1, 
increasing dietary protein intake to 3.0 g⋅kg BW-1 “possibly attenuated” psychological 
symptoms of stress experienced during training, and “possibly reduced” decrements in 
performance following intensified training. Although the aformentioned findings were 
not statistically significant, this study highlights the potential importance of protein 
supplementation during periods of intensified training.  
 A few recent studies have suggested that CHO+Pro supplementation may also 
augment cardiovascular adaptations following training (16, 33–35). CHO+Pro 
supplementation has been associated with increased serum albumin content and plasma 
volume, resulting in increased stroke volumes, lower heart rates, and enhancements in 
thermoregulatory responses to heat. These results have been observed following both 
short (~5 days) and long (~8 wks) training periods (7, 12, 16, 34, 35). An increase in 
plasma albumin content will draw fluid from the extravascular space into the 
intravascular space due to oncotic pressure leading to an increase in plasma volume (8, 
14). The increase in plasma volume appears to enhance thermoregulatory responses to 
heat, such as an increased sweat rate and a lower esophageal temperature (16).  The rate 
of albumin synthesis has been linked to dietary protein intake (13). Therefore the increase 




However these results have only been directly observed in studies comparing CHO+Pro 
supplements to placebo treatments (as opposed to CHO), and only in studies examining 
untrained subjects.   
 There is also indirect evidence suggesting that CHO+Pro may augment 
cardiovascular adaptations. Ferguson-Stegall et al. (11) reported that CHO+Pro 
(chocolate milk) supplementation throughout 4.5 weeks of aerobic training resulted in 
greater increases in VO2max values compared to CHO alone. The authors speculated that 
these effects were the result of enhanced cardiovascular adaptations with CHO+Pro 
ingestion, as discussed previously.  Furthermore, Cathcart et al. (7) recently investigated 
the effects of CHO+Pro supplementation on thermoregulatory capacity, exercise 
performance, and recovery during eight days of competitive mountain biking in a hot 
environment. Subjects competing in the TransAlp mountain bike race were divided into a 
CHO group (76 g⋅L-1 CHO) and a CHO+Pro group (18 g⋅L-1 Pro and 72 g⋅L-1 CHO) and 
given enough beverages to consume ad libitum during each stage of the race. Subjects 
consuming the CHO+Pro supplement completed stages 2-8 of the race significantly 
quicker and maintained both body mass and body temperature more effectively 
throughout the multi-day race. These findings provide preliminary evidence that trained 
subjects may derive cardiovascular benefits from CHO+Pro supplementation of sufficient 
magnitude to improve their performance in subsequent exercise.  
 Few studies have investigated the effects of CHO+Pro supplementation on 
exercise tolerance during intensified training periods longer than a few days duration. 
Furthermore, we are aware of no studies that have systematically investigated the impact 




trained subjects. Therefore the primary aims of this study are to determine if a) CHO+Pro 
supplementation during and following exercise results in better maintenance of exercise 
performance during 10 days of intensified cycle training in trained cyclists compared to 
CHO b) CHO+Pro supplementation during and following exercise enhances exercise 
performance following 10 days of reduced volume training in trained cyclists compared 
to CHO and c) changes in cardiovascular physiology may explain potential performance 
differences between treatments. We hypothesize that the use of CHO+Pro 
supplementation during and following exercise will attenuate impairments in endurance 
performance following intensified training. We also hypothesize that CHO+Pro 
supplementation will amplify improvements in endurance performance following 
reduced-volume training. We expect that changes in cardiovascular responses with 
training will be positively affected by the CHO+Pro supplementation and will (at least 




• Subjects will accurately complete all self-reported forms. 
• Intensified cycle training will result in a state of overreaching. 
 
Limitations: 
• Small sample size 
• May not be generalizable to athletes who perform less…. 
 
Delimitation: 
• Cyclists with training of ≥ 7 hours a week, for at least two months prior to the 
study 








1. Intensified cycle training (ICT): Training volume that is 100% greater than 
normal training. 
 
2. Overtraining: A state in which performance decrements, global mood disruptions, 
and increased feelings of fatigue occur after repeated bouts (~7days) of high 
intensity exercise with little recovery. 
 
3. Performance Decrements: Time trial performance that has become worse than 







 Five endurance-trained cyclists (4 males and 1 female) were recruited to 
participate in this study. All cyclists were between the ages of 18-55 and had a training 
history of ≥ 7 hours per week of cycle training for ≥ 2 months prior to the study. A 
general health questionnaire was used to assess each participant’s health status, and 
informed consent was obtained before participation in this study. Subjects were required 
to demonstrate a peak aerobic capacity (VO2 peak) of ≥ 50 ml·kg-1·min-1 prior to entry into 
the study. Participants were given a detailed explanation of the experimental procedures 
and required commitment. Individuals with preexisting injuries, or with milk allergies 
were excluded from study participation. The James Madison University’s Institutional 
Review Board approved all procedures prior to the start of the study. 
 
Experimental Design 
 The study consisted of two 27-day training periods. The training periods consisted 
of 7 days of normal training (NT), 10 days of intensified cycle training (ICT) 
characterized by ~ 100% increase in average daily training volume relative to NT, and 10 
days of reduced volume training (RVT) (Figure 3.1). RVT commenced immediately after 
ICT and consisted of ~60% of the average daily training volume relative to NT. A 2-
week or greater washout period was provided between the training periods. 
Familiarization and preliminary testing was conducted during the seven days preceding 




periods subjects were provided with either a carbohydrate (CHO) or carbohydrate plus 
protein (CHO+Pro) recovery beverage during and immediately following each cycling 
session. Subjects completed this design in a random treatment order and both the subjects 




 Prior to the beginning of this study subjects performed an incremental test to 
exhaustion on an electrically braked cycle ergometer (Velotron, Racermate Inc, Seattle 
WA) to determine VO2peak, and maximal power output (Wmax). Briefly, subjects warmed-
up for 5 minutes at a self-selected, moderate workload. The workload was increased by 
25 W every 2 minutes until subjects voluntarily requested to stop due to fatigue or were 
unable to continue at a cadence >50 rpm. Metabolic measurements (including VO2, CO2, 
RER, and ventilation) were obtained at 30-second intervals during each stage of the test 
using indirect calorimetry via an automated Moxus Modular Metabolic System (AEI 




(Brooklyn, NY). Heart rate and RPE, using Borg’s 6 to 20 scale, were recorded every 60 
s. This initial test was used to obtain the VO2peak used for inclusion/exclusion, and as a 
familiarization trial for subsequent VO2peak!testing. Subjects also completed a 
familiarization time-trial (TT). This took place the week before ICT and was completed 
on a computerized electrically braked cycle ergometer (Velotron, Racermate Inc, Seattle 
WA). The TT consisted of 120 minutes of cycling at 50% Wmax (obtained from VO2peak 
testing) followed by a simulated 30-km time trial (as described below). No measurements 
were taken during this TT, other than power output and time to completion. 
 
Experimental Training 
 Following baseline data collection, subjects began NT. Subjects were asked to 
complete and record a typical week of training during this time. Each subject was 
provided with a training diary to record all training sessions, and a rear bicycle wheel 
equipped with an integrated PowerTap system (Saris Cycling Group Inc, Madison WI), 
allowing subjects to monitor daily workouts with the recording of power output (WAvg). 
These tools were used to quantify power output, HR, and baseline training loads (distance 
covered, and time). From this data, training duration (minutes) was used to quantify 
training volume. Immediately following NT, subjects performed 10 days of ICT. During 
the ICT phase, subjects were required to complete a 100% work increase of their daily 
average training volume relative to NT. This magnitude of overload is comparable to 
previously used training protocols that resulted in impaired performance following ICT 
(10, 19). On days 1, 4, 7, & 10 of ICT, and day 10 of RVT an endurance performance test 




endurance performance tests contributed to the total training load during ICT. The 
remaining days of ICT were performed outside of the laboratory. During this time 
subjects were provided with detailed training guidelines that were based on 
individualized training volume to ensure a 100% increase in training volume was being 
met. Outside of the lab, to ensure proper training volume, the subject monitored and 
recorded HR, power output, and training duration, using the same methods discussed 
previously. Immediately following ICT, subjects performed 10 days of RVT consisting of 
a 60% reduction in average training volumes (relative to NT). Ten days of reduced 
volume training has been shown to restore/improve cycling performance (18, 45). During 
all exercise sessions and immediately post exercise, CHO and CHO+Pro beverages were 
provided, as described below.  A two-week washout period (WO) followed the 
completion of the RVT phase. WO consisted of an individualized initial period of 
recovery, with the intent of restoring normal training loads by the end of the washout 
period. Following the washout period, subjects completed one week of NT (matching the 
training volumes/intensities from the first NT period), before initiating a second phase of 
ICT and RVT training (while consuming the second beverage treatment).  
 
Nutritional Supplements 
 During ICT and RVT subjects were provided with CHO or CHO+Pro beverages 
to consume during and immediately following each training session. During all 
laboratory TT sessions (Figure 2), subjects ingested 250 ml of fluid every 20 minutes 
until TT completion (750 ml·hr-1; details provided below).  For all rides performed in the 




ml bottles filled with the appropriate beverage, and instructed to ingest 1 bottle during 
each 40-minute block of training (750 ml·hr-1). Following each ride, participants were 
given bottles containing an individualized volume of fluid (see details below) and 
instructed to finish the beverage within 30 minutes of terminating exercise. Participants 
avoided any other beverage or food intake for 2 hrs following the completion of each 
exercise session, with the exception of ad libitum water consumption.  
 The during-exercise CHO treatment was a commercial sports drink containing 6% 
CHO by volume (Gatorade®). During all training sessions CHO was ingested at a rate of 
45 g CHO·hr-1 (750 ml·hr-1), providing equal carbohydrate content to CHO+Pro. The 
post exercise CHO recovery beverage provided 1.2 g CHO·kg BW-1. The beverage was 
created by mixing the appropriate amount of commercially available chocolate flavored 
carbohydrate gels (Clif Shots) with water, providing a similar taste and color to the post 
exercise CHO+Pro beverage (low-fat chocolate milk).  
 The during-exercise CHO+Pro treatment was Gatorade® (6% CHO by volume) 
with additional hydrolyzed whey protein isolate (2% Pro by volume). The CHO+Pro 
beverage was ingested at a rate of 750 ml·hr-1, providing equal fluid and carbohydrate 
content to the CHO treatment. The post-exercise CHO+Pro beverage was 9.93 ml·kg 
BW-1 of a low-fat chocolate milk beverage, providing 1.2 g CHO·kg BW-1. This provided 
equal calories and carbohydrates to the post-exercise CHO beverage. 
 
Dietary Controls 
 Subjects met with a dietician prior to the beginning of the study. During this 




daily intakes was provided. Also, 72-hour dietary records were gathered during NT, 
whereupon individualized feedback was provided about total caloric- and macronutrient 
intake; participants with inadequate daily carbohydrate intake (<6.5 g·kgBW-1·day-1) 
were encouraged to increase their dietary carbohydrate levels prior to the training 
intervention.  Dietary intake was also recorded throughout ICT (10 days) and RVT (10 
days). The dietary intake was analyzed using Nutrition Data System for Research 
software (NDSR, University of Minnesota) producing a detailed outline of macro and 
micro nutrient intake. During the time period between the onset of each training session 
and 2 hours following each training session, participants did not receive any nutrients 
other than the CHO or CHO+Pro beverages. All laboratory testing (i.e. VO2peak tests, and 
TT) was performed after an 8-10 hr overnight fast (ad libitum water consumption). 
Following each laboratory test a standardized lunch was provided. The lunch was chosen 
prior to starting the study according to participate preferences. Each lunch contained 1-2 
standard sandwiches, chips or a cookie, and water. Using copies of dietary records 
obtained from the first intervention phase, subjects were instructed to replicate their 
dietary habits during the second phase of the cross-over design. Subjects were also 
provided with nutritional choices to match previous intake, helping to maintain a similar 
diet between phases. 
 
Performance Measurements 
Endurance Performance: To determine endurance performance subjects completed TTs 
on a computerized cycle ergometer (VeloTron, Racermate Inc., Seattle WA), on days 1, 
4, 7, & 10 of ICT and on day 10 of RVT. Upon arrival at the laboratory, subjects were 




performed a preload consisting of 120 minutes of cycling at 50% Wmax followed by a 
simulated 30-km time trial. The only information provided to subjects during the time 
trial was distance completed. 30-km TT finishing times and average power output were 
used as performance measures.  
VO2peak (aerobic capacity): Subjects performed an incremental exercise test to 
exhaustion on a bicycle ergometer (Velotron), as described above, on day 7 of NT, day 9 
of ICT, and day 9 of RVT (Figure 2). The highest sustainable (30 seconds) power output 
(Wmax) was used to calculate exercise intensities for the 120-minute preload segment of 





Respiratory Exchange Ratio, VO2, Blood Lactate and Glucose, and Heart Rate: 
Breath samples were obtained at minutes 25-30, 55-60, 85-90, and 115-120 of the 120-
min preload TT during all 10 TT. The final three minutes of gas collection at each time 
point were aggregated to represent a mean for VO2, expired ventilation (VE), and 
respiratory exchange ratio (RER). Finger stick blood samples were also obtained at these 
same time points. Blood glucose (Glu) and lactate levels (Lac) were immediately 
analyzed using an automated tabletop analyzer (YSI 2300 STAT glucose/lactate analyzer, 
Yellow Springs, OH). Submaximal and peak heart rate (HR) were assessed during each 
VO2peak test and throughout the 120-minute submaximal preload segment of each TT on 
days 1 and 10 of ICT and day 10 of RVT. Heart rate was obtained using Polar heart-rate 




Plasma Albumin, Hemoglobin, and Hematocrit: Fasting venous blood samples were 
obtained from an antecubital vein prior to TT on days 1 and 10 of ICT and day 10 of 
RVT. Plasma albumin was assessed using standard enzyme-linked immunosorbent assay 
(ELISA) procedures. Finger stick blood samples were also obtained at these same time 
points. Hemoglobin (Hgb) and hematocrit (Hct) were immediately analyzed using a 
Hemo Control hemoglobin and hematocrit analyzer (EKF Diagnostics, London, United 
Kingdom). 
Ratings of Perceived Exertion (RPE): RPE was recorded every 30 minutes during the 
120-minute preload during each of the 10 TT.  
 
Statistical Analysis 
Statistical testing was conducted using SPSS version 17.0 (Thomson Learning, Pacific 
Grove, CA), using an alpha level of p < 0.05 for all analyses. Two-way ANOVAs 
(treatment*time) were used to determine differences between treatments for all variables.  
 Due to limitation in examining performance-related measurements with 
traditional null hypothesis testing, magnitude-based inferences about the data were made 
using methods described by Hopkins and colleagues (22). 90% confidence intervals (CI) 
are presented to illustrate uncertainty in treatment effects. Threshold values for 
substantial change were calculated as 0.2 x SD (from CHO trial). A published 
spreadsheet (5) was use to classify treatment effects as beneficial/positive, 
harmful/negative, or trivial/negligible. Likelihoods of reaching the substantial change 




25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = very likely, and >99% = 






Figure 2. Study Schematic with Corresponding Data Collection 
VO2Pk = VO2peak, TT = preloaded time trial 
Note: This design was repeated twice (Figure 1). Therefore, days -1, -2, and -3 correspond to the final 3 days of normal training,  
whereas day +1 corresponds to day 1 of washout or study completion."
"
 
    Intensified Cycling Training 
 Reduced Volume Training  
Days -3 -2 -1 1 2 3 4 5 6 7 8 9 10  1 2 3 4 5 6 7 8 9 10 +1 
VO2Pk   X         X           X   








Effects of carbohydrate + protein co-ingestion during and following exercise on 
cardiovascular adaptations and exercise tolerance during intensified cycle training. 
 
Abstract 
Introduction: This study investigated the effects of carbohydrate and protein (CHO+Pro) 
supplementation during intensified training on cardiovascular adaptations and cycling 
performance.  Methods: Five cyclists (VO2peak = 62.6 ± 10.7 ml/kg/min) performed two 
27-day training protocols while receiving either CHO or CHO+Pro supplements. The 
exercise protocols consisted of 7 days of normal training (NT), 10 days of intensified 
cycle training (ICT; 100% increase in average training duration versus NT), and 10 days 
of reduced volume training (RVT; reduction in training duration to 60% of NT). 
Performance was assessed by a 30-km time trial following 120 min of constant-load 
cycling and VO2peak testing. Other physiological measures were assessed at rest (heart 
rate, hematocrit, hemoglobin, and albumin) and during exercise (heart rate, ventilation, 
RER, RPE, VO2, glucose, and lactate). Supplements were consumed during exercise (750 
ml·hr-1; CHO = 6% concentration; CHO+PRO = 6% CHO, 2% Pro concentrations) and 
immediately following exercise (9.93 ml of fluid·kg BW- 1; CHO = 1.2 g CHO·kg BW-1; 
CHO+PRO = 1.2 g CHO·kg BW-1 + 0.3 g Pro·kg BW-1). Data was analyzed using 
magnitude-based inferences. Results: Time to complete the 30-km TT and average TT 
power were ‘likely’ impaired following ICT, with no differences between treatments. 
Following RVT, time to complete the 30-km TT and average TT power were ‘likely’ 





likely’!larger!reduction!with!CHO+Pro!(135±13 bpm to 128±10 bpm) versus CHO 
(133±15 bpm to 132±13 bpm). Between NT and RVT, constant-load HR also ‘very 
likely’ declined to a greater extent with CHO+Pro (135±13 bpm to 132±14) than with 
CHO (133±15 to 138±16 bpm). Serum albumin was ‘likely’ increased following ICT and 
RVT (independent of treatment), but differences between treatments were ‘unclear’. 
Conclusion: These findings suggest exercising heart rates in well trained-cyclists are 
attenuated with carbohydrate and protein supplementation, although the cause of the 
reduced in HR is unclear. In addition, the implications of these findings require further 
study, as overall exercise tolerance and adaptations following intensified training were 






 Endurance athletes often utilize periods of intensified training in an attempt to 
enhance performance. However, sustained periods of heavy training with inadequate 
recovery can lead to symptoms of non-functional overreaching/overtraining, such as 
impaired performance, and increases in negative mood states and perceived exertion 
during exercise (16, 17, 21). Nutritional interventions have been successfully utilized to 
promote recovery during periods of intensified training. For example, increased 
carbohydrate (CHO) intake immediately following exercise has been shown to improve 
glycogen re-synthesis (39, 40), and result in better maintenance of performance and mood 
following heavy training (1, 15, 39, 40). 
 In recent years numerous studies have reported that co-ingestion of carbohydrate 
and protein (CHO+Pro) during short-term recovery following heavy exercise improves 
performance in subsequent exercise versus CHO alone (2, 4, 6, 8, 20, 22, 30, 37, 42). 
Enhanced glycogen re-synthesis (5, 19, 24, 45), and/or reduced muscle damage (12, 14, 
25–27, 36, 41, 43) are possible explanations for improvements in performance, though 
not all studies have reported these benefits (7, 34, 36, 38). Despite evidence from short-
term studies, the effects of CHO+Pro ingestion on exercise tolerance, training adaptations 
and performance during sustained periods of heavy training/competition are poorly 
understood. A few studies have investigated CHO+Pro supplementation during 3-6 days 
of training, and reported reductions in markers of muscle damage, such as creatine kinase 
(CK) (12, 25, 41) and muscle soreness (25). However, it is unclear whether regular intake 
of CHO+Pro beverages has a positive impact on performance following heavy training to 




protein led to “possibly attenuated” psychological stress symptoms, and “possibly 
reduced” decrements in performance following a week of intensified training. However, 
this study compared large differences in dietary protein intake (CON: 1.5 g Pro·kg BW-1; 
Pro: 3.0 g Pro·kg BW-1), and did not specifically examine supplemental protein intake 
provided during and/or following exercise. 
 Recent studies have suggested that CHO+Pro supplementation may also augment 
cardiovascular adaptations following training (13, 31–33).  Specifically, CHO+Pro 
supplementation has been associated with increased serum albumin content and plasma 
volume, resulting in increased stroke volume, lower heart rate, and enhancements in 
thermoregulatory responses to heat (8, 11, 13, 32, 33). However these results have only 
been directly observed in studies comparing CHO+Pro supplements to placebo treatments 
(as opposed to CHO), and only in studies examining untrained subjects. Ferguson-Stegall 
et al. (10) reported that subjects receiving CHO+Pro  supplementation throughout 4.5 
weeks of aerobic training had greater increases in VO2max compared to those receiving 
CHO. The authors speculated that these effects were probably the result of enhanced 
cardiovascular adaptations with CHO+Pro ingestion, but cardiovascular variables were 
not directly assessed. Furthermore, Cathcart and associates (8) reported that cyclists 
receiving CHO+Pro supplementation during eight days of competitive mountain biking 
had better performance times and enhanced thermoregulatory responses compared to 
those receiving CHO (8). However, this was a field-based study, which prevented the 
standardization of a variety of factors, including exercise intensity, which presumably 
varied substantially throughout each race stage. This makes it impossible to determine the 




Therefore, these findings provide preliminary evidence that trained subjects may derive 
cardiovascular benefits from CHO+Pro supplementation, but this hypothesis has yet to be 
examined in controlled studies. Therefore, the purpose of this study was to examine the 
effects of CHO+Pro supplementation (versus CHO) on cardiovascular responses and 
exercise performance during intensified cycle training, and following a subsequent period 





 Five endurance-trained cyclists (4 males and 1 female) were recruited to 
participate in this study. Inclusion criteria for this study were that all cyclists were 
between the ages of 18-55 and had a training history of ≥ 7 hours per week of cycle 
training for ≥ 2 months prior to the study. A general health questionnaire was used to 
assess each participant’s health status, and informed consent was obtained before 
participation in this study. Subjects were required to demonstrate a peak aerobic capacity 
(VO2peak) of ≥ 50 ml·kg-1·min-1 prior to entry into the study. Participants were given a 
detailed explanation of the experimental procedures and required commitment. 
Individuals with preexisting injuries or milk allergies were excluded from participation. 
The James Madison University’s Institutional Review Board approved all procedures 
prior to the start of the study. 
Experimental Design 
 The study consisted of two 27-day training periods. The training periods consisted 
of 7 days of normal training (NT), 10 days of intensified cycle training (ICT) 




volume relative to NT, and 10 days of reduced volume training (RVT) (Figure 3.1). RVT 
commenced immediately after ICT and consisted of a training prescription of ~60% of 
the average daily training volume relative to NT. A 2-week or greater washout period 
was provided between the training periods. Familiarization and preliminary testing was 
conducted during the seven days preceding the initial training block (i.e. after 1 week of 
NT). During ICT and RVT training subjects were provided with either carbohydrate 
(CHO) or carbohydrate plus protein (CHO+Pro) beverages during and immediately 
following each cycling session. Subjects completed this design in a random treatment 
order and both the subjects and researchers were blinded to the CHO and CHO+Pro 
treatments.  Female subjects started each 27-day training block on the same day of their 
menstrual cycle to minimize the impact of menstrual phase on responses between 
treatments. 
 











 Prior to the beginning of this study subjects performed an incremental test to 
exhaustion on an electrically braked cycle ergometer (Velotron, Racermate Inc, Seattle 
WA) to determine VO2peak, and maximal power output (Wmax). Briefly, subjects warmed-
up for 5 minutes at a self-selected, moderate workload. The workload was increased by 
25 W every 2 minutes until subjects voluntarily requested to stop due to fatigue or were 
unable to continue at a cadence >50 rpm. Metabolic measurements (including VO2, CO2, 
RER, and ventilation) were obtained at 30-second intervals during each stage of the test 
using indirect calorimetry via an automated Moxus Modular Metabolic System (AEI 
Technologies, Bostrop TX).  Heart rate was obtained using a Polar heart rate monitor 
(Brooklyn, NY). Heart rate and RPE, using Borg’s 6 to 20 scale, were recorded every 
60s. This initial test was used to obtain the VO2peak used for inclusion/exclusion, and as a 
familiarization trial for subsequent VO2peak testing. Subjects also completed a 
familiarization time-trial (TT). This took place the week before ICT and was completed 
on a computerized electrically braked cycle ergometer (Velotron, Racermate Inc, Seattle 
WA). The TT consisted of 120 minutes of cycling at 50% Wmax (obtained from VO2peak 
during preliminary testing) followed by a simulated 30-km time trial (as described 
below). No measurements were taken during this TT, other than power output and time to 
completion. 
Experimental Training 
 Following preliminary testing, subjects began NT. Subjects were asked to 
complete and record a typical week of training during this time. Each subject was 




equipped with an integrated PowerTap system (Saris Cycling Group Inc, Madison WI), 
allowing subjects to monitor daily workouts with the recording of power output (WAvg). 
These tools were used to quantify power output, HR, and baseline training loads (distance 
covered and time). From this data, training duration (minutes) was used to quantify 
training volume. Immediately following NT, subjects performed 10 days of ICT. During 
the ICT phase, subjects were prescribed a training load which doubled their daily average 
training volume during NT. This magnitude of overload is comparable to previously used 
training protocols that resulted in impaired performance following ICT (9, 16). On days 
1, 4, 7, & 10 of ICT, and day 10 of RVT, an endurance performance test (time-trial) was 
conducted, lasting approximately three hours (described below). These endurance 
performance tests contributed to the total training load during ICT and RVT. The 
remaining days of ICT were performed outside of the laboratory. During this time 
subjects were provided with detailed training guidelines that were based on 
individualized training volume to ensure a 100% increase in training volume was being 
met. Outside of the lab, to ensure proper training volume, the subject monitored and 
recorded HR, power output, and training duration, using the same methods discussed 
previously. Immediately following ICT, subjects performed 10 days of RVT, which 
consisted of a reduction in average training volume to 60% of NT. Ten days of reduced 
volume training has been shown to restore/improve cycling performance (15, 44). During 
all exercise sessions and immediately post exercise, CHO and CHO+Pro beverages were 
provided, as described below.  A two-week washout period (WO) followed the 
completion of the RVT phase. WO consisted of an individualized initial period of 




period. Following the washout period, subjects completed one week of NT (matching the 
training volumes/intensities from the first NT period), before initiating a second phase of 
ICT and RVT training (while consuming the second beverage treatment).  
Nutritional Supplements 
 During ICT and RVT subjects were provided with CHO or CHO+Pro beverages 
to consume during and immediately following each training session. During all 
laboratory TT sessions (Figure 2), subjects ingested 250 ml of fluid every 20 minutes 
until TT completion (750 ml of fluid·hr-1; details provided below).  For all rides 
performed in the field (ICT days 2, 3, 5, 6, 8, 9 and RVT days 2-10), participants were 
provided with 500 ml bottles filled with the appropriate beverage, and instructed to ingest 
1 bottle during each 40-minute block of training (750 ml of fluid·hr-1). Following each 
ride, participants were given bottles containing an individualized volume of fluid (see 
details below) and instructed to finish the beverage within 30 minutes of terminating 
exercise. Participants avoided any other beverage or food intake for 2 hrs following the 
completion of each exercise session, with the exception of ad libitum water consumption.  
 The during-exercise CHO treatment was a commercial sports drink containing 6% 
CHO by volume (Gatorade®). During all training sessions CHO was ingested at a rate of 
45 g CHO·hr-1 (750 ml of fluid·hr-1), providing equal carbohydrate content to CHO+Pro. 
The post exercise CHO recovery beverage provided 1.2 g CHO·kg BW-1. The beverage 
was created by mixing the appropriate amount of commercially available chocolate 
flavored carbohydrate gels (Clif Shots) with water, providing a similar taste and color to 




 The during-exercise CHO+Pro treatment was Gatorade® (6% CHO by volume) 
with additional hydrolyzed whey protein isolate (2% Pro by volume) (American Casein 
Company, Burlington NJ, USA). The CHO+Pro beverage was ingested at a rate of 750 
ml of fluid·hr-1, providing equal fluid and carbohydrate content to the CHO treatment. 
The post-exercise CHO+Pro beverage was 9.93 ml of fluid·kg BW-1 of a low-fat 
chocolate milk beverage, providing 1.2 g CHO·kg BW-1. This provided equal 
carbohydrates to the post-exercise CHO beverage. 
Dietary Controls 
 Subjects met with a registered dietician prior to the study. During this meeting, a 
food scale was supplied and specific information regarding how to weigh and record 
daily intakes was provided. 72-hour dietary records were gathered during NT, whereupon 
individualized feedback was provided about total caloric- and macronutrient intake; 
participants with inadequate daily carbohydrate intake (<6.5 g·kgBW-1·day-1) were 
encouraged to increase their dietary carbohydrate levels prior to the training intervention.  
Dietary intake was also recorded throughout ICT (10 days) and RVT (10 days). During 
the time period between the onset of each training session and 2 hours following each 
training session, participants did not receive any nutrients other than the CHO or 
CHO+Pro beverages. All laboratory testing (i.e. VO2peak tests, and TT) was performed 
after an 8-10 hr overnight fast (ad libitum water consumption). Following each laboratory 
test a standardized lunch was provided. The lunch was chosen prior to starting the study 
according to participant preferences. Each lunch contained 1-2 standard sandwiches, 
chips or a cookie, and water. Using copies of dietary records obtained from the first 




second phase of the cross-over design. Subjects were also provided with nutritional 
choices to match previous intake, helping to maintain a similar diet between phases. 
Performance Measurements 
Endurance Performance: To determine endurance performance subjects completed TTs 
on a computerized cycle ergometer (VeloTron, Racermate Inc., Seattle WA), on days 1, 
4, 7, and 10 of ICT and on day 10 of RVT. Subjects initially performed a preload 
consisting of 120 minutes of cycling at 50% Wmax followed by a simulated 30-km time 
trial. The only information provided to subjects during the time trial was distance 
completed. 30-km TT finishing times and average power output were used as 
performance measures.  
VO2peak (aerobic capacity): Subjects performed an incremental exercise test to exhaustion 
on a bicycle ergometer (Velotron), as described above, on day 7 of NT, day 9 of ICT, and 
day 9 of RVT (Figure 2), under both treatment conditions. The highest sustainable (30 
seconds) power output (Wmax) was used to calculate exercise intensities for the 120-
minute preload segment of the TT (50% Wmax obtained during preliminary VO2peak test). 
Test duration (time to fatigue) was also used as a measure of performance. 
Metabolic/Cardiovascular Measurements 
 
Respiratory Exchange Ratio, VO2, Blood Lactate and Glucose, and Heart Rate: Breath 
samples were obtained at minutes 25-30 and 115-120 of the 120-min preload TT during 
all 10 TT. The final three minutes of gas collection at each time point were aggregated to 
represent a mean for VO2, expired ventilation (VE), and respiratory exchange ratio 
(RER). Finger stick blood samples were also obtained at these same time points. Blood 




tabletop analyzer (YSI 2300 STAT glucose/lactate analyzer, Yellow Springs, OH). 
Submaximal and peak heart rate (HR) were assessed during each VO2peak test and 
throughout the 120-minute submaximal preload segment of each TT on days 1 and 10 of 
ICT and day 10 of RVT. Heart rate was obtained using Polar heart-rate monitors 
(Brooklyn, NY). 
Plasma Albumin, Hemoglobin, and Hematocrit: Fasting venous blood samples were 
obtained from an antecubital vein prior to TT on days 1 and 10 of ICT and day 10 of 
RVT. Plasma albumin was assessed using standard enzyme-linked immunosorbent assay 
(ELISA) procedures. Finger stick blood samples were also obtained at these same time 
points. Hemoglobin (Hgb) and hematocrit (Hct) were immediately analyzed using a 
Hemo Control hemoglobin and hematocrit analyzer (EKF Diagnostics, London, United 
Kingdom). 
Ratings of Perceived Exertion (RPE): RPE was recorded at minutes 30 and 120 during 
the 120-minute preload during each of the 10 TT.  
Statistical Analysis 
Statistical testing was conducted using SPSS version 17.0 (Thomson Learning, Pacific 
Grove, CA). Two-way repeated measures ANOVAs (treatment*time) were used to 
determine effects between time-points (i.e. NT vs. ICT), and treatment*time effects for 
all variables.  
 Due to limitations in examining performance-related measurements with 
traditional null hypothesis testing, magnitude-based inferences about the data were made 
using methods described by Hopkins and colleagues (18). Threshold values for 




spreadsheet (18) was use to classify treatment effects as beneficial/positive, 
harmful/negative, or trivial/negligible. Likelihoods of reaching the substantial change 
threshold were classified as <1% almost certainly no chance, 1-5% = very unlikely, 5-
25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = very likely, and >99% = 
almost certain (44). Effects were described as unclear if confidence intervals overlapped 





Figure 2. Study Schematic with Corresponding Data Collection 
VO2Pk =VO2peak, TT = preloaded time trial 
Note: This design was repeated twice (Figure 1). Therefore, days -1, -2, and -3 correspond to the final 3 days of normal training,  
whereas day +1 corresponds to day 1 of washout or study completion.
 
    Intensified Cycling Training 
 
Reduced Volume Training  
Days -3 -2 -1 1 2 3 4 5 6 7 8 9 10 
 
1 2 3 4 5 6 7 8 9 10 +1 
VO2Pk   X         X           X   
TT    X   X   X   X 
 






 Statistical analyses were conducted on data from the 5 subjects (4 male and 1 
female) who completed all testing. Average (±SD) age, height, weight, maximal oxygen 
consumption (VO2peak), and work max (Wmax) of the participants were 27.6 ± 8.2 y, 176.4 
± 8.3 cm, 74.4 ± 10.2 kg, 62.6 ± 10.7 ml/kg/min, 330 ± 60 watts, respectively.  
Training Duration and Intensity 
 As illustrated in Table 1, training duration increased (100%) between NT and ICT 
(‘mostly likely’, p < 0.001) in both treatments. With respect to training intensity, average 
training heart rate ‘very likely’ decreased (p = 0.025) during ICT (independent of 
treatment). Similarly, average power output during ICT was ‘likely’ (p = 0.072) lower 
than NT. Treatment*time interactions between NT-ICT were ‘very likely’ for power (p = 
.063) and ‘possible’ for duration (p = .396). Changes were ‘unclear’ for HR.  
Training duration during RVT was reduced to approximately 60% of NT duration 
(‘mostly likely’, p < 0.001) with no differences between treatments. With respect to 
training intensity, heart rate responses during RVT were similar to NT (‘unclear’), while 
average power output was ‘possibly’ higher (p = .149) during RVT (independent of 
treatment). A treatment*time interaction between NT-RVT was ‘very likely’ for power (p 




Table 1: Training Data 



















CHO 72±6 142±17.4 184±34 143±13 134±12 169±34 43±4 141±11 186±38 
CHO+Pro 74±6 140±12 173±32 147±13 132±10 171±31 44±5 139±9 186±40 
CHO=carbohydrate; CHO+Pro=carbohydrate + protein 
Time-effects:   
Changes between NT-ICT were ‘Mostly Likely’ for: Duration; Changes were ‘Very Likely’ for: HR; Changes were ‘Likely’ for: Power  
Changes between NT-RVT were ‘Mostly Likely’ for: Duration; Changes were ‘Possible’ for: Power; Changes were ‘Unclear’ for: HR 
Treatment*time effects: 
Changes between NT-ICT were ‘Very Likely’ for: Power; Changes were ‘Possible’ for: Duration; Changes were ‘Unclear’ for: HR 





Effects of Training and Treatment Beverages 
Endurance Performance and Aerobic Capacity 
 Table 2 displays cycling performance variables following NT, ICT, and RVT 
under both treatment conditions. Independent of treatment, VO2peak Time was ‘very 
likely’ decreased (p = 0.050) following ICT. Similarly, Average TT Power was ‘likely’ 
decreased (p = 0.144 and TT Time ‘likely’ increased (p = 0.215) following ICT. Changes 
in VO2peak were ‘possible’ between NT-ICT (p=0.473), and changes in Wmax were ‘trivial’ 
(p = 0.426). All other variables demonstrated ‘unclear’ differences between these time-
points. A treatment*time interaction between NT-ICT was ‘likely’ for VO2peak (p 
=0.178), with all other treatment*time effects ‘unclear’. 
The RVT period also altered cycling performance measurements. Average TT 
Power (p = 0.061), VO2peak time (p = 0.089), and TT time (p=.071) were ‘likely’ 
increased from ICT to RVT (independent of treatment). Changes from ICT to RVT were 
‘trivial’ for VO2peak (p = 0.640) and Wmax (p = 0.305), with changes in all other variables 
’unclear’. Treatment*time interactions between ICT-RVT were ‘possible’ for Average 
TT Power (p = 0.570) and Wmax (p = 0.621), with changes in all other variables ’unclear’. 
 When comparing performance variables from NT to RVT there was a ‘likely’ 
increase in VO2peak (p =0.187). Changes in TT Time (p = 0.667) and Average TT Power 
(p = 0.624) were ‘trivial’, and all other variable were ‘unclear’. Treatment*time 





Table 2: Performance Measurements Following Each Training Period 
 Normal Training Intensified Training Reduced Volume Training 
 CHO CHO+Pro CHO CHO+Pro CHO CHO+Pro 
TT Time 
(min) 54.9±5.9 54.8±7.2 57.3±10.1 57.6±9.5 55.1±6.4 55.5±9.5 
Average TT 
Power (watts) 204±52 213±60 194±63 190±57 203±48 210±72 
VO2peak 
(ml/kg/min) 63.4±10.8 63.7±12.0 66.9±8.7 62.6±13.3 67.0±12.0 64.1±13.7 
Wmax  
(watts) 330±65 330±76 320±57 325±61 330±57 330±60 
VO2peak Time 
(min) 14.3±3.2 14.7±4.6 12.4±2.1 12.6±2.4 13.4±2.6 13.5±3.2 
CHO=carbohydrate; CHO+Pro=carbohydrate + protein. 
Time-effects:   
Changes between NT-ICT were ‘Very Likely’ for VO2peak Time; Changes were ‘Likely’ for: TT Time and Average TT 
Power; Changes were ‘Possible’ for: VO2peak; Changes were ‘Trivial’ for: Wmax; All other variables were ‘Unclear’. 
Changes between ICT-RVT were ‘Likely’ for: Average TT Power, VO2peak Time, and TT Time; Changes were 
‘Trivial’ for: VO2peak, and Wmax. 
Changes between NT-RVT were ‘Trivial’ for: TT Time, Average TT Power, and VO2peak; All other variable were 
‘Unclear’ 
Treatment*time effects: 
Changes between NT-ICT were ‘Likely’ for: VO2peak; All other variables were ‘Unclear’. 
Changes between ICT-RVT were ‘Possible’ for: Average TT Power and Wmax; All other variables were ‘Unclear’ 
Changes between NT-RVT were ‘Unclear’ for all variables 
 
Cardiovascular Measurements at Rest 
 Table 3 displays resting cardiovascular measurements after NT, ICT, and RVT for 
both treatment conditions. Albumin was ‘likely’ increased (p = 0.122) from NT to ICT, 
independent of treatment. All other variables displayed ‘unclear’ effects over time, and 
all treatment*time effects between NT-ICT were also ‘unclear’. 
 Changes between ICT-RVT were ‘likely’ for hemoglobin (p = 0.294), and 




All other variables were ‘unclear’. A treatment*time interaction between ICT-RVT was 
‘possible’ for hematocrit (p = 0.587), with effects for all other variables ‘unclear’. 
 Albumin (p = 0.120), hemoglobin (p = 0.096), and hematocrit (p = 0.140) were all 
‘likely’ increased from NT to RVT (independent of treatment). All other effects between 
these time-points were ‘unclear’. Treatment*time effects between NT-RVT were ‘likely’ 
for hemoglobin (p = 0.343), and ‘possible’ for hematocrit (p = 0.586). All other 




















Table 3: Cardiovascular Measurements at Rest 
 Normal Training Intensified Training Reduced Volume Training 
 CHO CHO+Pro CHO CHO+Pro CHO CHO+Pro 
HR 
(bpm) 
64±5 59±3 61±7 56±7 65±8 61±9 
Hgb 
(g/dl) 
14.8±1.0 15.0±1.5 15.1±1.5 15.0±2.2 15.9±1.9 15.3±2.0 
Hct  
(%) 
43.6±3.0 43.3±3.9 44.1±4.6 43.8±5.9 44.6±3.3 42.5±2.3 
Albumin 
(g/dl) 
5.5±1.0 5.4±0.8 6.1±0.6 5.8±0.5 6.4±0.6 6.0±0.7 
CHO=carbohydrate; CHO+Pro=carbohydrate + protein; HR=heart rate; Hgb=hemoglobin; 
Hct=Hematocrit. 
Time-effects:   
Changes between NT-ICT were ‘Likely’ for: Albumin; All other variables were ‘Unclear’ 
Changes between ICT-RVT were ‘Likely’ for: Hgb; Changes were ‘Possible’ for: Albumin, and Hct; All other 
variables were ‘Unclear’ 
Changes between NT-RVT were ‘Likely’ for: Albumin, Hgb, and Hct; All other variables were ‘Unclear’. 
Treatment*time effects: 
Changes between NT-ICT were ‘’Unclear’ for all variables 
Changes between ICT-RVT were ‘Possible’ for: Hct; All other variables were ‘Unclear’ 






Figure 3: Plasma Albumin Concentration Following Each Training Period 
 
Data reported as mean ± SD; CHO=carbohydrate; CHO+Pro=carbohydrate + protein; NT=normal 
training; ICT=intensified cycle training; RVT=reduced volume training. 
 
 
Constant Load Metabolic/Cardiovascular Measurements 
 Table 4 and Figure 3 display the metabolic and cardiovascular responses during 
constant-load exercise during NT, ICT, and RVT. Early (30 min) and late (120 min) 
exercise responses are shown in Table 4.  However, because we observed no likely 
treatment*time*timepoint interactions,  we removed timepoint (30 min versus 120 min) 
from subsequent analyses to allow simpler interpretation.  Therefore, the treatment* time 
interactions reported below represent an aggregate value for the early and late time-points 
for all variables. Following ICT, there were ’likely’ increases in RPE (p = 0.166), and 




treatment. All other time effects between NT-ICT were ‘unclear’. Treatment*time 
interactions from NT to ICT were ‘very likely’ for HR (p = 0.045), and ‘likely’ for VE (p 
= 0.366) and RER (p = 0.293). All other treatment*time effects during this time-point 
were ‘unclear’.  
 Following the RVT period, there were ‘likely’ changes in VE (p = 0.087), RER (p 
= 0.424), and HR (p = 0.107) in comparison to ICT (independent of treatment). Changes 
were also ‘possible’ for VO2 (p = 0.968). All other variables were ‘unclear’. 
Treatment*time interactions between ICT-RVT were ‘very likely’ for lactate (p = 0.065), 
‘likely’ for glucose (p = 0.279), possible’ for VE (p = 0.892), and ‘trivial’ for VO2 (p = 
0.864); All other variables were ‘unclear’. 
 Changes in responses between NT-RVT were ‘trivial’ for VE (p = 0.486), VO2 (p 
= 0.060) and HR (p = 0.758) (independent of treatment). Effects for all other variables 
between NT-ICT were ‘unclear’. Treatment*time interactions were ‘very likely’ for HR 
(p = 0.054), and  ‘likely’ for RER (p = 0.146). In addition, changes were ‘possible’ for 




Table 4: Physiological Responses During Constant-Load Cycling 
  Normal Training Intensified Training Reduced Volume Training 
  CHO CHO+Pro CHO CHO+Pro CHO CHO+Pro 
Early 131±15 134±13 132±13 127±10 139±18 131±15 HR  
(bpm) Late 135±15 135±12 131±13 128±10 136±13 132±13 
Early 64.8±11.0 67.0±9.1 64.3±8.8 64.3±10.0 70.4±4.7 66.8±8.5 VE  
(L/min) Late 68.8±9.7 74.1±12.4 67.6±7.4 68.3±11.3 67.8±8.2 71.4±12.7 
Early 12.0±1.0 11.4±2.7 12.4±2.2 11.8±2.6 11.2±2.5 11.2±2.6 
RPE Late 12.8±0.8 12.2±0.1 13.6±1.7 13.2±1.6 12.6±2.5 12.4±2.7 
Early 0.81±.04 0.82±.02 0.83±.14 0.79±.04 0.87±.02 0.83±.03 
RER Late 0.81±.04 0.84±.03 0.82±.13 0.79±.05 0.85±.03 0.83±.04 
Early 38.0±6.6 37.9±8.1 36.5±3.9 36.4±6.9 37.2±3.9 36.2±9.0 VO2 
(ml/kg/min) Late 38.8±7.3 39.4±9.0 37.2±4.7 37.4±6.5 36.7±6.4 37.3±10.7 
Early 90.3±8.1 79.2±10.6 93.7±8.7 78.9±11.5 89.9±4.7 83.8±8.1 Glu  
(mg/dl) Late 81.8±7.3 78.6±2.8 81.7±4.6 76.2±6.7 76.7±0.5 73.9±6.5 
Early 1.3±0.4 1.1±0.5 0.9±0.1 1.1±0.4 1.2±0.6 0.7±0.5 Lac 
(mmol/L) Late 1.7±1.1 0.9±0.2 1.2±0.4 1.2±0.4 1.1±0.4 1.1±0.7 
CHO=carbohydrate; CHO+Pro=carbohydrate + protein; HR=heart rate; VE=ventilation; RPE=rating of 
perceived exertion; RER=respiratory exchange ratio; Glu=glucose; Lac=lactate; Early=30 minutes; 
Late=120 minutes. 
Time-effects:   
Changes between NT-ICT were ‘Likely’ for: RPE, VE, and HR; All other variables were ‘Unclear’. 
Changes between ICT-RVT were ‘Likely; for: VE, RER, and HR; Changes were ‘Possible’ for: VO2; All 
other variables were ‘Unclear’ 
Changes between NT-RVT were ‘Trivial’ for: VE, VO2, and HR; All other variable were ‘Unclear’ 
Treatment*time effects: 
Changes between NT-ICT were ‘Very Likely’ for: HR; Changes were ‘Likely’ for: VE and RER; All 
other variables were ‘Unclear’ 
Changes between ICT-RVT were ‘Very Likely’ for: Lac; Changes were ‘Likely’ for: Glu; Changes were 
‘Possible’ for: VE; Changes were ‘Trivial’ for: VO2; All other variables were ‘Unclear’ 
Changes between NT-RVT were ‘Very Likely’ for: HR; Changes were ‘Likely’ for: RER; Changes were 









Figure 4: Heart Rate During Constant Load Exercise 
 
Data reported as mean ± SD; CHO=carbohydrate; CHO+Pro=carbohydrate + protein; HR=heart 




Effects of the Intensified Training Model 
 The intensified training period was intended to elicit a state of overreaching in 
subjects, characterized by short-term decrements in exercise performance. Average daily 
training duration was increased by ~100% compared to NT for 10 days. Subjects were 
instructed to maintain their normal training intensity during ICT. However, we observed 




respectively. These changes probably reflect the subjects’ inability to maintain training 
intensity due to fatigue incurred by the more than two-fold increase in training duration 
that occurred during ICT. This is similar to findings by Costill et al. (9), Jeukendrup et al. 
(21), and Halson et al. (16) who implemented similar training protocols to the one 
utilized in this study and observed significant decrements in training intensity after 
completion of a period of heavy training. Following the ICT period, we observed ‘likely’ 
impairments in TT time, average TT power, and VO2peak time; and higher constant load 
RPE. These findings are similar to other studies that have examined the effects of 
intensified training loads on performance (1, 9, 16, 44), and are consistent with a state of 
‘overreaching’ in athletes. 
 The RVT period was utilized to allow subjects to recover following ICT, and was 
intended to restore or improve performance compared to baseline measurements. During 
RVT subjects reduced average training duration to ~60%  of NT, for 10 days. This 
reduction in training load was similar to prior studies which have effectively restored 
performance levels following intensified training (15, 44). Following RVT, there were 
‘likely’ improvements in TT time, average TT power and VO2peak time, compared to ICT. 
As a result of these changes, markers of endurance performance generally returned to 
baseline levels following RVT. However there did not appear to be any significant 
improvements in performance compared to baseline levels, which has been observed by 
some (21, 28). The reasons for this lack of performance improvement are unclear. 
However it is possible that the proportional increases in training volume, or length of the 
ICT period were excessive, leading subjects into a state of  ‘non-functional’, rather than 




performance that is reversed when an appropriate period of recovery is implemented, as 
opposed to ‘non-functional’ overreaching, which is when performance decrements persist 
following a planned recovery period (29). Similarly, the RVT period may not have been 
long enough to allow full recovery from the increased training stimulus, allowing a return 
to baseline performance but no improvements through training adaptations. Recovery 
periods are planned with the intent that subjects will derive a supercompensation 
response; however, there is substantial inter-individual variation in required recovery 
times. Therefore, the absence of performance improvements following intensified 
training periods is not uncommon, and has been reported in studies using similar training 
protocols to those used in this study (15, 16). Nevertheless, the training protocols elicited 
the desired effects for the purposes of this study, with reduced performance following 
ICT and restored performance following RVT - allowing a meaningful comparison in 
responses between treatments. 
Effects of Treatment Beverages on Training Responses 
 The primary purpose of this study was to examine the effects of CHO+Pro 
supplementation on exercise tolerance and training adaptations, particularly 
cardiovascular adaptations, to this intensified training/recovery model in well-trained 
cyclists. The most important finding was that CHO+Pro supplementation attenuated 
constant load HR following ICT and RVT in comparison to CHO (Figure 4 and Table 4). 
Ventilation and RER were also ‘likely’ decreased after ICT with CHO+Pro 
supplementation, but the magnitude of these changes were quite small, and both returned 
to near-baseline levels following RVT. A lowered exercising HR response with 




al. (13) examined the effects of CHO+Pro supplementation on cardiovascular adaptations 
in untrained subjects, who completed five consecutive days of aerobic exercise (30 
minutes at 70% VO2peak). Subjects who received CHO+Pro supplementation (CHO: 8.3 
g/100 mL, Pro: 5.6 g/100 mL) following the exercise sessions had significantly greater 
decreases in HR during submaximal exercise than those receiving a placebo. Similarly 
Okazaki et al. (33) reported lower exercise HR’s in older males who consumed CHO+Pro 
following exercise during an 8-week training program (60 min at 60-75% VO2peak, 3 days 
a week). These studies illustrate the potential influence of CHO+Pro supplementation on 
HR responses during exercise. However, both studies were conducted using previously 
untrained subjects, and CHO+Pro supplementation was not compared to a supplement 
containing equal CHO content. Therefore it is unclear whether these effects would persist 
in trained athletes, or if the adaptations were elicited by protein per se. Cathcart et al. (8) 
examined the effects of CHO+Pro supplementation in cyclists during a competitive 
mountain biking race. CHO or CHO+Pro supplements (in liquid and solid form) were 
consumed during each day of an 8-day competition. Mean HR’s during each stage of the 
race tended to be lower with CHO+Pro ingestion, but were not significantly different 
between groups. However, the highly applied (and field-based) nature of this study 
prevented the standardization of a variety of factors (such as the amount of nutrients 
consumed, exercise intensities, etc.) that could have influenced study outcomes, making 
direct interpretations of these findings difficult. To our knowledge, our study is the first 





 A possible explanation for reduced constant-load HR may be protein-mediated 
increases in plasma volume. Goto el al. (13) and Okazaki et al. (33) reported increases in 
plasma albumin content with CHO+Pro supplementation. This has been proposed to 
cause an oncotic pressure gradient, resulting in fluid shifts from the extra-vascular space 
to the intra-vascular space, expanding plasma volume. Plasma volume expansion leads to 
an enhanced venous return to the heart, which stretches cardiopulmonary 
mechanoreceptors, resulting in enhancements in stroke volume, and reductions in HR 
(31). Plasma albumin levels were assessed in the present study (Figure 3 and Table 3); 
however we did not observe any significant differences between treatments. Plasma 
volume and stroke volume were not directly assessed in this study so we can only 
speculate as to whether this had an effect on exercising HR. In addition to decrements in 
HR, protein-mediated changes in stroke volume have also been reported to augment 
VO2peak in prior studies (10, 33); but VO2peak was not increased with CHO+Pro in our 
study, despite the suppressed constant-load HR. Therefore, out data does not directly 
support an increased plasma volume and stoke volume as a mechanism for the lower HR 
response during constant load exercise. 
 The observed reduction in exercising HR is presumed to be a positive adaptation 
to training/supplementation because of its association with reduced cardiac strain and 
improved thermoregulation (8, 13, 33). Goto et al. (13) and Okazaki et al. (33) observed 
improvements in vasodilation and sweat rate following CHO+Pro supplementation, 
which were associated with an increase in plasma volume. As a result, CHO+Pro 
supplementation has been reported to enhance the maintenance of body temperature 




possible that overtraining led to hypothalamic dysfunction, which could have caused the 
lower exercising heart rates. Lehmann et al. (23) reported elevated catecholamine levels 
and decreased constant-load HRs following a period of increased training volume that 
was intended to elicit overtraining. The authors speculated that the lower exercising HR 
might have been due to decreased sensitivity to catecholamines. This decrement in 
sensitivity is indicative of decreased intrinsic sympathetic activity, a dysfunction which 
has been described as ‘central fatigue’ in exhausted athletes (3). Therefore, it is possible 
that the decrement in constant load HR, which occurred following ICT in the CHO+Pro 
condition, was due to ‘central fatigue’. However, if this were the case, subjects would 
likely have also reported an increased RPE during exercise (16). In addition, we would 
expect that the decrease in HR would have been restored, along with the observed 
improvements in exercise performance, following RVT, if the cause of the lowered HR 
response had been central fatigue. Because neither of these changes occurred, we propose 
that the decrement in constant load HR was not due to hypothalamic dysfunction. In 
support of this theory, Halson et al. (15) reported a decrease in exercising heart rate 
following ICT and RVT with supplemental carbohydrate consumption. However, the 
decreased heart rate was only statistically significant in the higher-carbohydrate 
condition, which is notable because various markers of overtraining were also attenuated 
in this condition. This suggests that the reduced heart rate was a positive training 
adaptation, rather than  a response to central fatigue. However, further study is required 
to fully support this position. 
 CHO+Pro supplementation during and/or following heavy exercise has been 




studies (2, 4, 6, 8, 20, 22, 30, 37, 42); however not all studies have observed this finding 
(5, 7). Despite the reduced constant-load heart rate which occurred with CHO+Pro in the 
present study, we did not observe any evidence of enhanced exercise performance with 
CHO+Pro. There are a few potential explanations for this finding. Firstly, it is possible 
that the present study design was not adequately powered to detect meaningful 
differences in performance. Due to the large number of performance tests, and the 
comparatively lengthy timeline of the training protocol (which may have increased 
variability in performance measures), it is possible that a larger number of subjects was 
required to detect nutritionally-mediated changes in performance. It is also possible that 
CHO+Pro does not enhance performance during/following intensified training when 
individuals are already consuming adequate dietary protein. Witard et al. (44) 
manipulated dietary protein levels in subjects during one week of intensified training. 
Despite substantial increases in protein intake (3.0 g Pro·kg BW-1), cycling time-trial 
performances following ICT and RVT were virtually identical to when subjects were 
consuming lower protein amounts, which were consistent with most current dietary 
recommendations (1.5 g Pro·kg BW-1) (44). Similarly, preliminary data from three 
subjects in the present study shows that protein intake (independent of supplementation) 
was 1.6 g·kg BW-1 per day during ICT. These findings suggest that supplemental protein 
intake during/following exercise does not enhance exercise performance following 
intensified training, provided that dietary intake is adequate. 
 Although the decrement in exercising HR with CHO+Pro supplementation was 
not accompanied by improved cycling performance, it is worth noting that maintenance 




Average training power ‘likely’ decreased following the ICT period, but the magnitude of 
the reduction was ‘possibly’ less with CHO+Pro. In addition, average training power 
during the RVT period was ‘possibly’ increased versus NT, with ‘very likely’ larger 
increases in the CHO+Pro condition. Berardi et al. (4) have reported similar findings 
during a short-term intervention, with a CHO+Pro supplement providing better 
maintenance of power output in a subsequent exercise trial on the same day. Rowlands 
and associates have also noted improvements in power output following four days of 
heavy training with CHO+Pro supplementation (35), but not all studies have reported this 
outcome (36). These results suggest CHO+Pro supplementation could allow better 
maintenance of self-selected training intensities, potentially contributing to long-term 
benefits in performance. However, this interpretation should be made cautiously, as the 
predominant factor in our noted differences between treatments was an 11 W (‘likely’) 
difference in power outputs during the NT phase. Thus, it cannot be directly concluded 
that power outputs during training were higher with CHO+Pro supplementation. 
 In conclusion, our results suggest that constant-load HR is attenuated in well-
trained cyclists following 10 days of intensified training with CHO+Pro supplementation, 
and that this adaptation persists following 10 days of reduced volume training. Changes 
in serum albumin concentration were similar between CHO and CHO+Pro treatments, 
and changes in plasma volume were not assessed, so it is unclear what mechanism may 
explain the observed reduction in exercise HR. In addition, changes in performance 
measures following ICT and RVT were similar between treatments. Thus, it appears that 
overall tolerance to intensified training, and adaptations following a period of recovery 




exercise. It is possible that potential differences between treatments could be magnified 
with a larger sample size. Future studies should also measure cardiac output and plasma 
volume changes during and following training to better understand possible 
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